ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,090Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1121

$1.83M Total Retail Price of All Prescriptions

Rank: 8 out of 1121

663 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 18,218 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 873 608 1 1
LEVOTHYROXINE SODIUM 848 594 2 2
FUROSEMIDE 764 485 3 7
LISINOPRIL 670 482 4 4
POTASSIUM CHLORIDE 624 371 5 12
AMLODIPINE BESYLATE 610 400 6 5
OMEPRAZOLE 578 325 7 6
METFORMIN HCL 576 364 8 8
GABAPENTIN 538 325 9 13
ALLOPURINOL 503 299 10 30
CITALOPRAM HBR 471 319 11 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 435 221 12 31
NEXIUM 417 313 13 24
WARFARIN SODIUM 416 280 14 11
ATORVASTATIN CALCIUM 408 265 15 15
SPIRIVA 397 191 16 49
LOSARTAN POTASSIUM 382 232 17 17
MELOXICAM 342 194 18 22
CLOPIDOGREL 341 230 19 27
METOPROLOL TARTRATE 335 209 20 9
BACLOFEN 329 182 21 131
HYDROCODONE-ACETAMINOPHEN 327 271 S3 22 3
METOPROLOL SUCCINATE 309 191 23 23
CELEBREX 292 215 24 104
CRESTOR 289 178 25 28
SPIRONOLACTONE 260 126 26 54
RANITIDINE HCL 254 109 27 33
CARVEDILOL 249 191 28 20
LOVASTATIN 244 156 29 26
JANUVIA 242 176 30 81
DIOVAN 240 193 31 45
ADVAIR DISKUS 235 138 32 64
PLAVIX 231 141 33 42
CYMBALTA 230 97 34 50
PROAIR HFA 230 101 34 48
GLIMEPIRIDE 222 139 36 34
TRAZODONE HCL 220 127 37 40
JANUMET 217 116 38 167
LEVOCETIRIZINE DIHYDROCHLORIDE 202 131 39 263
PRAVASTATIN SODIUM 196 133 40 14
SERTRALINE HCL 194 152 41 21
DOXEPIN HCL 185 149 42 191
DIGOXIN 181 121 43 59
NAMENDA 180 169 44 53
HYDROCHLOROTHIAZIDE 171 114 45 10
SINGULAIR 162 85 46 78
CILOSTAZOL 157 88 47 214
CYCLOBENZAPRINE HCL 156 99 R 48 83
PANTOPRAZOLE SODIUM 156 99 48 29
LOSARTAN-HYDROCHLOROTHIAZIDE 154 115 50 46
TAMSULOSIN HCL 147 117 51 32
PAROXETINE HCL 143 103 52 58
LAMOTRIGINE 139 90 53 187
PRAMIPEXOLE DIHYDROCHLORIDE 138 87 54 158
NABUMETONE 136 70 55 145
LEVEMIR FLEXPEN 134 66 56 222
AZITHROMYCIN 133 83 57 44
LIPITOR 129 89 58 106
METHYLPREDNISOLONE 129 72 58 97
ATENOLOL 126 103 60 16
AMITRIPTYLINE HCL 125 70 R 61 61
DIOVAN HCT 124 54 62 90
IBUPROFEN 123 65 63 110
AMLODIPINE BESYLATE-BENAZEPRIL 123 76 63 65
RISPERIDONE 120 97 65 82
BUSPIRONE HCL 115 72 66 114
PREDNISONE 109 77 67 43
ISOSORBIDE MONONITRATE ER 105 79 68 62
ESCITALOPRAM OXALATE 101 76 69 94
SYNTHROID 100 78 70 55
FLUOXETINE HCL 99 73 71 60
TRICOR 98 87 72 126
ROPINIROLE HCL 97 75 73 91
TRIAMTERENE-HCTZ 97 86 73 38
ATELVIA 95 86 75 264
FLUTICASONE PROPIONATE 95 36 75 36
THEOPHYLLINE ANHYDROUS 92 67 77 175
LACTULOSE 90 41 78 132
DONEPEZIL HCL 89 75 79 35
VESICARE 88 59 80 186
PEN NEEDLE 85 41 81 137
MONTELUKAST SODIUM 84 44 82 144
KLOR-CON M20 83 53 83 85
DIVALPROEX SODIUM 83 43 83 98
ZOLPIDEM TARTRATE 82 54 85 19
QUETIAPINE FUMARATE 80 58 86 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 52 87 108
LANTUS SOLOSTAR 77 50 88 109
BYSTOLIC 77 35 88 121
ACTOS 75 48 90 133
AMOX TR-POTASSIUM CLAVULANATE 75 40 90 101
METHOCARBAMOL 74 46 R 92 159
METOLAZONE 72 45 93 238
LANTUS 72 55 93 52
ALENDRONATE SODIUM 71 56 95 37
EXELON 71 62 95 119
EXFORGE 70 70 97 190
VENTOLIN HFA 69 23 98 92
ZETIA 69 39 98 80
HYDROXYZINE PAMOATE 68 12 R 100 282
LYRICA 68 0 100 76
AMIODARONE HCL 67 44 102 188
NOVOLOG FLEXPEN 63 40 103 228
SPIRONOLACTONE-HCTZ 63 40 103 240
RAMIPRIL 61 35 105 74
LEVOFLOXACIN 60 35 106 79
MIRTAZAPINE 58 47 107 56
VALACYCLOVIR 58 41 107 455
CIPROFLOXACIN HCL 58 44 107 57
LANSOPRAZOLE 57 36 110 162
CEFDINIR 57 39 110 183
VENLAFAXINE HCL ER 56 31 112 113
IBANDRONATE SODIUM 55 41 113 363
INSULIN SYRINGE 54 38 114 77
SYMBICORT 53 23 115 148
HYDROXYCHLOROQUINE SULFATE 53 30 115 265
CLONIDINE HCL 53 21 115 39
NASONEX 52 28 118 260
HYDRALAZINE HCL 51 30 119 66
PROPRANOLOL HCL 51 43 119 123
CLOBETASOL PROPIONATE 51 32 119 396
TOPIRAMATE 51 23 119 202
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.